AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL
· Real-Time Price · USD
2.48
-0.01 (-0.40%)
At close: May 02, 2025, 12:46 PM
AbCellera Biologics Revenue
AbCellera Biologics reported an annual revenue of $28.83M, reflecting a -24.17% growth. For the quarter ending December 31, 2024, AbCellera Biologics generated $5.05M in revenue.
Revenue (ttm)
$28.83M
Revenue Growth
-24.17%
Price / Sales Ratio
29.91
Revenue / Employee
$48.38K
Employees
596
Market Cap
737.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|